Sökning: "Mikael Hedeland"
Visar resultat 1 - 5 av 15 avhandlingar innehållade orden Mikael Hedeland.
1. Cellobiohydrolase I as a chiral sector
Sammanfattning : The protein cellobiohydrolase I (CBH I) immobilized on silica particles has been used as a chiral selector in liquid chromatography (LC) and the free enzyme has served as a chiral complexing agent in the background electrolyte in capillary electrophoresis (CE) using the partial tilling technique.The CE systems were much more efficient and more solutes could be enantioseparated than in the LC systems. LÄS MER
2. Synthesis and spectroscopic characterization of emerging synthetic cannabinoids and cathinones
Sammanfattning : The application of different analytical techniques is fundamental in forensic drug analysis. In the wake of the occurrence of large numbers of new psychoactive substances possessing similar chemical structures as already known ones, focus has been placed on applied criteria for their univocal identification. LÄS MER
3. Analytical Methods For Sports Drugs: Challenges and Approaches
Sammanfattning : Drugs used to enhance human performance in sport competitions are prohibited by the world anti-doping association (WADA). Biological samples from athletes are continuously tested for adverse analytical findings regarding the identity and/or quantity of the banned substances. LÄS MER
4. Analytical method development in liquid chromatography- mass spectrometry based metabolomics
Sammanfattning : Metabolomics is the analytical field which aims at analyzing all small molecules, metabolites, in a biological system simultaneously. Currently no analytical methods are able to capture the entire metabolome, therefore, the analytical methods are often developed to be as general as possible. LÄS MER
5. Analytical Quality by Design Method Development for Vaccine Characterization
Sammanfattning : Vaccines that are safe, efficacious, and can be rapidly developed are needed to prevent and to react to emerging global infectious disease threats such as influenza, Polio, and Coronavirus diseases. Fast and reliable analytical methods are required without delay to support vaccine process and product development, characterization, and quality control testing. LÄS MER